BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$465M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$329M |
| 3 |
Procter & Gamble
PG
|
$261M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
$238M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$227M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$830M |
| 2 |
SPDR Gold Trust
GLD
|
$563M |
| 3 |
Invesco QQQ Trust
QQQ
|
$195M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$171M |
| 5 |
Alibaba
BABA
|
$159M |
Sector Composition
| 1 | Technology | 10.15% |
| 2 | Financials | 8.84% |
| 3 | Communication Services | 8.44% |
| 4 | Consumer Discretionary | 6.71% |
| 5 | Healthcare | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Charles River Laboratories
CRL
$7.99B
| $14.2M | 0.06% |
170,577
+144,702
| +559% | +$12.1M |
|
227
Teva Pharmaceuticals
TEVA
$21.5B
| $14.2M | 0.06% |
308,517
+88,350
| +40% | +$4.06M |
|
228
Medtronic
MDT
$118B
| $14.1M | 0.06% |
163,209
-36,128
| -18% | -$3.12M |
|
229
Ford
F
$46.2B
| $14.1M | 0.06% |
1,165,410
-376,190
| -24% | -$4.54M |
|
230
MetLife
MET
$53.6B
| $13.8M | 0.06% |
311,478
-80,574
| -21% | -$3.58M |
|
231
Integra LifeSciences
IART
$1.18B
| $13.7M | 0.06% |
166,252
-14,175
| -8% | -$1.17M |
|
232
American Water Works
AWK
$27.5B
| $13.7M | 0.06% |
183,114
-42,633
| -19% | -$3.19M |
|
233
iShares S&P 500 Value ETF
IVE
$40.9B
| $13.3M | 0.05% |
140,412
+30,500
| +28% | +$2.9M |
|
234
Colgate-Palmolive
CL
$67.7B
| $13.3M | 0.05% |
179,838
-88,571
| -33% | -$6.57M |
|
235
Campbell Soup
CPB
$10.1B
| $13.2M | 0.05% |
241,422
-11,555
| -5% | -$632K |
|
236
WisdomTree Japan Hedged Equity Fund
DXJ
$3.72B
| $13.2M | 0.05% |
307,477
-452,605
| -60% | -$19.4M |
|
237
Western Digital
WDC
$29.8B
| $13.2M | 0.05% |
225,050
+85,407
| +61% | +$4.99M |
|
238
AES
AES
$9.42B
| $13.1M | 0.05% |
1,019,624
+304,825
| +43% | +$3.92M |
|
239
Monster Beverage
MNST
$62B
| $12.9M | 0.05% |
87,635
+67,605
| +338% | +$9.93M |
|
240
AGNC Investment
AGNC
$10.4B
| $12.8M | 0.05% |
655,246
-13,814
| -2% | -$270K |
|
|
ENDP
241
DELISTED
Endo International plc
ENDP
| $12.7M | 0.05% |
629,554
-778
| -0.1% | -$15.7K |
|
|
LSXMA
242
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $12.7M | 0.05% |
373,209
+431
| +0.1% | +$14.6K |
|
243
Best Buy
BBY
$15.8B
| $12.5M | 0.05% |
326,268
+3,562
| +1% | +$136K |
|
244
Abbott
ABT
$230B
| $12.3M | 0.05% |
290,060
-131,464
| -31% | -$5.56M |
|
245
iShares US Utilities ETF
IDU
$1.64B
| $12.3M | 0.05% |
+100,000
| New | +$12.3M |
|
246
Parker-Hannifin
PH
$94.8B
| $12.3M | 0.05% |
97,601
+48,160
| +97% | +$6.05M |
|
247
Kinder Morgan
KMI
$59.4B
| $12.2M | 0.05% |
541,389
-331,714
| -38% | -$7.49M |
|
248
Paychex
PAYX
$48.8B
| $12.2M | 0.05% |
211,203
+134,245
| +174% | +$7.77M |
|
249
Illumina
ILMN
$15.2B
| $12.2M | 0.05% |
67,242
+26,144
| +64% | +$4.75M |
|
250
Lazard
LAZ
$5.19B
| $12.2M | 0.05% |
335,419
-27,287
| -8% | -$992K |
|